What is the recommended cefuroxime dosing regimen for streptococcal pharyngitis in children and adults who cannot take penicillin?

Cefuroxime Dosing for Streptococcal Pharyngitis

Cefuroxime is NOT a preferred agent for streptococcal pharyngitis and should only be used when narrow-spectrum cephalosporins are unavailable or contraindicated in penicillin-allergic patients. 1

Why Cefuroxime is Not Recommended

The 2012 IDSA guidelines explicitly classify cefuroxime as a broad-spectrum cephalosporin that is NOT preferred for treating Group A streptococcal (GAS) pharyngitis 1. The guideline strongly recommends narrow-spectrum cephalosporins (cefadroxil or cephalexin) instead, as broad-spectrum agents like cefuroxime:

• Are considerably more expensive than penicillin or amoxicillin
• Select for antibiotic-resistant flora
• Have unnecessarily broad antimicrobial coverage 1

If Cefuroxime Must Be Used

Oral Dosing (Cefuroxime Axetil)

Adults and adolescents (≥13 years):

• 250 mg twice daily for 10 days 2, 3

Children (ages 3-12 years):

• 125 mg (or 10 mg/kg, maximum 250 mg) twice daily for 10 days 4, 5
• Alternative: 20 mg/kg/day divided twice daily (maximum 500 mg/day) 6

Parenteral Dosing (Cefuroxime Sodium)

Adults:

• 750 mg IV/IM every 8 hours for a minimum of 10 days 7

Children (>3 months):

• 50-100 mg/kg/day IV/IM divided every 6-8 hours 7

Critical Duration Requirement

All treatment courses must be 10 days minimum to prevent rheumatic fever and glomerulonephritis, regardless of the antibiotic used 1, 7. The FDA label explicitly states: "a minimum of 10 days of treatment is recommended in infections caused by Streptococcus pyogenes in order to guard against the risk of rheumatic fever or glomerulonephritis" 7.

Short-Course Evidence Does Not Apply

While research shows 4-5 day courses of cefuroxime axetil achieved similar bacteriological eradication rates as 10-day penicillin courses 6, 4, 2, 5, the IDSA guidelines explicitly state that short-course cephalosporin therapy cannot be endorsed 1. These studies:

• Lacked strict entry criteria
• Did not adequately assess compliance
• Failed to differentiate treatment failures from new infections
• Were conducted in low-risk populations where rheumatic fever is rare 1

Only three FDA-approved antibiotics (cefdinir, cefpodoxime, azithromycin) have 5-day approval for GAS pharyngitis—cefuroxime is not among them 1.

Preferred Alternatives for Penicillin-Allergic Patients

First-line alternatives (in order of preference):

1. Narrow-spectrum cephalosporins (if no anaphylactic penicillin allergy):

   • Cephalexin or cefadroxil for 10 days 1

2. Clindamycin (if immediate hypersensitivity to penicillin):

   • ~1% GAS resistance in the US 1

3. Macrolides (azithromycin, clarithromycin):

   • 5-8% resistance rates in most US areas
   • 10 days for clarithromycin; 5 days for azithromycin 1

Key Caveats

• Do not use cephalosporins in patients with anaphylactic-type penicillin allergy—up to 10% cross-reactivity exists 1
• Cefuroxime's broader spectrum increases cost and resistance selection without improving outcomes for this indication
• In regions with high rheumatic fever prevalence, strict adherence to 10-day courses is essential 8
• Only one case of glomerulonephritis occurred across large studies (in the penicillin group), with no cases in cefuroxime-treated patients 2, but sample sizes remain insufficient to definitively assess rare complications